Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership75,873 shares
Latest Disclosed Value $ 852,048
Sei Investments Co ownership in AVNS / Avanos Medical, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 75,873 shares of Avanos Medical, Inc. (US:AVNS) valued at $852,054 USD as of December 31, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Avanos Medical, Inc.. The current value of the position is $1,895,308 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AVANOS MED COM 05350V106 75,873 75,873 852 0.0008
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 0 -12,654 -100.00 0 -100.00
2025-05-14 2025-03-31 13F/A-1 AVANOS MED COM 05350V106 12,654 12,654 181 0.0002
2025-05-13 2025-03-31 13F AVANOS MED COM 05350V106 12,654 12,654 183 0.0002
2025-02-11 2024-12-31 13F AVANOS MED COM 05350V106 0 -13,840 -100.00 0 -100.00
2024-11-12 2024-09-30 13F AVANOS MED COM 05350V106 13,840 13,840 333 0.0004
2024-05-07 2024-03-31 13F AVANOS MED COM 05350V106 0 -17,069 -100.00 0 -100.00
2024-02-14 2023-12-31 13F AVANOS MED COM 05350V106 17,069 -1,967 -10.33 383 -0.52 0.0006
2023-11-14 2023-09-30 13F AVANOS MED COM 05350V106 19,036 -3,339 -14.92 385 -32.75 0.0007
2023-08-11 2023-06-30 13F AVANOS MED COM 05350V106 22,375 2,856 14.63 572 -1.55 0.0010
2023-05-12 2023-03-31 13F AVANOS MED COM 05350V106 19,519 19,519 581 0.0011
2023-02-10 2022-12-31 13F AVANOS MED COM 05350V106 0 -18,456 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AVANOS MED COM 05350V106 18,456 -1,482 -7.43 402 -22.99 0.0009
2022-08-15 2022-06-30 13F AVANOS MED COM 05350V106 19,938 19,938 522 0.0011
2021-08-06 2021-06-30 13F AVANOS MED COM 05350V106 0 -10,865 -100.00 0 -100.00
2021-05-12 2021-03-31 13F AVANOS MED COM 05350V106 10,865 0 0.00 500 0.00 0.0013
2021-02-08 2020-12-31 13F AVANOS MED COM 05350V106 10,865 -431 -3.82 500 32.98 0.0013
2020-12-04 2020-09-30 13F/A-1 AVANOS MED COM 05350V106 11,296 11,296 376 0.0011
2020-11-06 2020-09-30 13F AVANOS MED COM 05350V106 11,400 11,400 379 912.5477
2019-08-14 2019-06-30 13F AVANOS MED COM 05350V106 0 -6,655 -100.00 0 -100.00
2019-05-15 2019-03-31 13F AVANOS MED COM 05350V106 6,655 -9,950 -59.92 284 -75.02 0.0010
2019-02-13 2018-12-31 13F AVANOS MED COM 05350V106 16,605 -8,175 -32.99 1,137 -32.52 0.0040
2018-11-08 2018-09-30 13F AVANOS MED COM 05350V106 24,780 -24,352 -49.56 1,685 -40.10 0.0061
2018-08-03 2018-06-30 13F HALYARD HEALTH COM 40650V100 49,132 23,366 90.69 2,813 136.98 0.0096
2018-05-11 2018-03-31 13F HALYARD HEALTH COM 40650V100 25,766 3,418 15.29 1,187 15.02 0.0046
2018-02-08 2017-12-31 13F HALYARD HEALTH COM 40650V100 22,348 -604 -2.63 1,032 -0.29 0.0036
2017-11-06 2017-09-30 13F HALYARD HEALTH COM 40650V100 22,952 4,707 25.80 1,035 44.35 0.0037
2017-07-31 2017-06-30 13F HALYARD HEALTH COM 40650V100 18,245 5,036 38.13 717 42.54 0.0029
2017-05-05 2017-03-31 13F HALYARD HEALTH COM 40650V100 13,209 503 3.96 503 7.02 0.0022
2017-02-02 2016-12-31 13F HALYARD HEALTH COM 40650V100 12,706 -259 -2.00 470 4.68 0.0023
2016-11-04 2016-09-30 13F HALYARD HEALTH COM 40650V100 12,965 4,063 45.64 449 55.36 0.0023
2016-08-11 2016-06-30 13F HALYARD HEALTH COM 40650V100 8,902 6,049 212.02 289 252.44 0.0017
2016-05-10 2016-03-31 13F/A-1 HALYARD HEALTH COM 40650V100 2,853 -124,458 -97.76 82 -98.07 0.0005
2016-02-03 2015-12-31 13F HALYARD HEALTH COM 40650V100 127,311 -28 -0.02 4,253 17.45 0.0259
2015-11-02 2015-09-30 13F/A-1 HALYARD HEALTH COM 40650V100 127,339 14,273 12.62 3,621 -20.92 0.0332
2015-10-30 2015-09-30 13F DIREXION SHS ETF TR COM 40650V100 127,339 3,622
2015-08-07 2015-06-30 13F/A-1 HALYARD HEALTH COM 40650V100 113,066 109,527 3,094.86 4,579 2,709.20 0.0414
2015-08-04 2015-06-30 13F HALYARD HEALTH COM 40650V100 113,066 109,527 4,579 0.0414
2015-05-14 2015-03-31 13F/A-1 HALYARD HEALTH COM 40650V100 3,539 1,582 80.84 163 91.76 0.0014
2015-05-01 2015-03-31 13F HALYARD HEALTH COM 40650V100 3,539 163
2015-02-10 2014-12-31 13F HALYARD HEALTH COM 40650V100 1,957 1,957 85 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.